Chemomab Therapeutics Ltd
F:2QV0
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Chemomab Therapeutics Ltd
F:2QV0
|
IL |
|
T
|
Thales SA
DUS:CSF
|
FR |
|
Y
|
Yokohama Rubber Co Ltd
F:YRB
|
JP |
|
C
|
China Life Insurance Co Ltd
OTC:CILJF
|
CN |
|
R
|
Ryanair Holdings PLC
OTC:RYAOF
|
IE |
|
S
|
Southwest Airlines Co
F:SWN
|
US |
|
L
|
Leonardo SpA
DUS:FMNB
|
IT |
|
Solutions 30 SE
PAR:S30
|
LU |
|
Kraft Heinz Co
NASDAQ:KHC
|
US |
|
Indel B SpA
F:2I6
|
IT |
|
Atomic Minerals Corp
XTSX:ATOM
|
CA |
|
D
|
Dupont De Nemours Inc
F:6D81
|
US |
|
Coca-Cola Europacific Partners PLC
NASDAQ:CCEP
|
UK |
|
P
|
Platinex Inc
CNSX:PTX
|
CA |
|
B
|
Beneteau SA
XBER:3GD
|
FR |
Bankruptcy Probability
Chemomab Therapeutics Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Chemomab Therapeutics Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IL |
|
Chemomab Therapeutics Ltd
NASDAQ:CMMB
|
19.4m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
443.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
211.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
180.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
132B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
54.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
82B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Chemomab Therapeutics Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Chemomab Therapeutics Ltd has no debt.
You can find a full breakdown on its Balance Sheet.
